Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-12

Clinical Trial Update: Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects

View source ↗

Summary

A completed clinical trial evaluated the cerebral effects of pegylated interferon in hepatitis C patients, and the results have been posted. The study contribut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegylated interferon (unspecified formulation) (pegylated interferon alfa)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Hepatitis C | Status: COMPLETED | Results posted: 2018-07-12